Join us now
The Calcitonin Gene-Related Peptide (CGRP) Forum has been established by an international group of clinicians and researchers. It provides all healthcare professionals with open and free access to independent news, information, comment and resources about the exciting potential of CGRP as a novel therapeutic target for the prevention of migraine in millions of people worldwide.
Real World Experience
Find out how other clinicians are using anti-CGRP therapies in their daily practice. Catch up with the latest real world data and share your experiences with colleagues around the world.Read more
Why is CGRP an important therapeutic target?
Multiple lines of evidence support a role for CGRP in migraine pathophysiology.
Its blockade is now a potentially important therapeutic target for migraine prevention.Read more Become a member
Is anti-CGRP therapy approved for your patients?
Take a look at our new expert guide to the regulatory status and approved indications for anti-CGRP therapies worldwide.Read More
2020 brought new hope for patients with migraine Anti-CGRP therapies - what can we expect in 2021? Migraine: a new treatment landscape View all Resources